Early Coronary Angiography Versus Delayed Coronary Angiography (PEARL)
Primary Purpose
Out-of-Hospital Cardiac Arrest, Hypothermia, Cardiac Arrest
Status
Terminated
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Early Angiography
Sponsored by
About this trial
This is an interventional treatment trial for Out-of-Hospital Cardiac Arrest
Eligibility Criteria
Inclusion Criteria:
- All successfully resuscitated out-of-hospital cardiac arrest patients with a suspected cardiac etiology for their non-traumatic arrest
- Age greater than 18 years
- The post resuscitation ECG shows no evidence of ST segment elevation
Exclusion Criteria:
- Non-resuscitated (no sustained pulse and BP)
- Presence ST segment elevation or new left bundle branch block present on the post-resuscitation ECG
- Suspected non-cardiac etiology for their arrest such as respiratory failure, asphyxia, pulmonary embolus, shock, trauma, drug overdose, or CNS bleed as likely cause of the cardiac arrest
- Known "Do Not Resuscitate" status
- Minors (<18 years old)
- Prisoners
- Significant bleeding or blunt trauma
- Known or confirmed pregnancy test by urinalysis
- Patients who are known to have received any other investigational therapies within the 30 days prior to enrollment or during study duration will be excluded unless these studies have been reviewed and approved by the Study Steering Committee.
- Known "opt out" choice; wearing Opt-out band for any EFIC approved study or on an "Opt-out" list
Sites / Locations
- Banner University Medical Center-South Campus
- Banner University Medical Center-Tucson Campus
- Tufts University School of Medicine, Maine Medical Center
- Mayo Clinic Cardiovascular Research Unit
- Alfred Hospital
- University Medical Center Ljubljana
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Interventional
Control Group
Arm Description
Early Angiography with purpose of coronary revascularization within 120 minutes of admission to ED, post out-of-hospital cardiac arrest, suspicious for cardiac etiology and no ST segment elevation on ECG
Standard of care treatment including therapeutic hypothermia in subjects post resuscitation, out-of-hospital cardiac arrest, suspicious for cardiac etiology and no ST segment elevation on ECG.
Outcomes
Primary Outcome Measures
Safety and Efficacy of early coronary angiography in the out-of-hospital cardiac arrest (OHCA) patient population.
Safety will be assessed by evaluating any association of major adverse events (re-arrest, bleeding, pulmonary edema, hypotension, acute renal insufficiency, and pneumonia) with early coronary angiography.
Secondary Outcome Measures
Survival from hospital at: 30 days post discharge and 180 days post discharge
Composite endpoint of improved left ventricular regional and global function (both regional wall motion analysis and left ventricular ejection fraction) as measured by echocardiography prior to hospital discharge, survival to discharge and favourable. Left ventricular regional function and left ventricular ejection fraction as measured by echocardiography will be measured prior to discharge or up to 180 days post hospital discharge.
Cognitive functional status
As measured by Modified Rankin Score (mRS) and Cerebral Performance Category (CPC) at multiple points up to 180 days post hospital discharge
Neurocognitive Testing
Neurocognitive function will be assessed at various time points utilizing a variety of tests from ICU discharge to 180 days post hospital discharge such as MMSE, MOCA, HADS, and IQCODE
Full Information
NCT ID
NCT02387398
First Posted
February 26, 2015
Last Updated
December 29, 2021
Sponsor
University of Arizona
Collaborators
MaineHealth, University Medical Centre Ljubljana, Mayo Clinic, The Alfred
1. Study Identification
Unique Protocol Identification Number
NCT02387398
Brief Title
Early Coronary Angiography Versus Delayed Coronary Angiography
Acronym
PEARL
Official Title
A Pilot Randomized Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography for Post-Cardiac Arrest Patients Without ECG ST Segment Elevation
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Funded study period, including a one-year no cost extension, completed.
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
October 31, 2018 (Actual)
Study Completion Date
April 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Arizona
Collaborators
MaineHealth, University Medical Centre Ljubljana, Mayo Clinic, The Alfred
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study is a pilot, multi-centered, randomized, clinical trial to evaluate the safety and efficacy of performing early Coronary Angiography (CAG) versus no early CAG in post-cardiac arrest patients without ST segment elevation. Safety will be assessed by evaluating the association of major adverse events (re-arrest, bleeding, pulmonary edema, hypotension, acute renal insufficiency, and pneumonia) with early coronary angiogram. Efficacy will be assessed by a composite endpoint of improved left ventricular regional and global function (both regional wall motion analysis and left ventricular ejection fraction) as measured by echocardiography prior to hospital discharge and favourable neurological function (Cerebral Performance Categories 1 or 2) at discharge.
Detailed Description
Cardiac arrest is a major public health issue. Arizona has been a leader in improving long-term survival by introducing new and innovative resuscitation approaches including "Chest Compression-Only CPR" and "Cardiocerebral Resuscitation". Post-resuscitation care is the next great opportunity for further improvements. Early coronary angiography (CAG) combined with therapeutic hypothermia has become the recommended standard of care for post-cardiac arrest patients manifesting ST segment elevation on their electrocardiogram (ECG). However, the majority of cardiac arrest victims do not have ST segment elevation. There is clinical equipoise as to whether these patients will benefit from early CAG.
Subjects who are qualified for the study will be randomized 1:1 to one of two groups.
° Intervention Group-Early coronary angiography (door-to-angiography) within 120 minutes of admission to Emergency Department.
or
° Control Group-No early coronary angiography (within the first six hours from admission)
All enrolled patients, will be treated with therapeutic hypothermia which is standard of care, beginning simultaneously with both groups or within at least 2 hours of hospital arrival.
Subject will be followed for 180 days for safety and long-term survival.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Out-of-Hospital Cardiac Arrest, Hypothermia, Cardiac Arrest
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
99 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Interventional
Arm Type
Experimental
Arm Description
Early Angiography with purpose of coronary revascularization within 120 minutes of admission to ED, post out-of-hospital cardiac arrest, suspicious for cardiac etiology and no ST segment elevation on ECG
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Standard of care treatment including therapeutic hypothermia in subjects post resuscitation, out-of-hospital cardiac arrest, suspicious for cardiac etiology and no ST segment elevation on ECG.
Intervention Type
Procedure
Intervention Name(s)
Early Angiography
Intervention Description
Coronary Angiography within 120 minutes of admission for out-of-hospital cardiac arrest with ROSC
Primary Outcome Measure Information:
Title
Safety and Efficacy of early coronary angiography in the out-of-hospital cardiac arrest (OHCA) patient population.
Description
Safety will be assessed by evaluating any association of major adverse events (re-arrest, bleeding, pulmonary edema, hypotension, acute renal insufficiency, and pneumonia) with early coronary angiography.
Time Frame
180 days
Secondary Outcome Measure Information:
Title
Survival from hospital at: 30 days post discharge and 180 days post discharge
Description
Composite endpoint of improved left ventricular regional and global function (both regional wall motion analysis and left ventricular ejection fraction) as measured by echocardiography prior to hospital discharge, survival to discharge and favourable. Left ventricular regional function and left ventricular ejection fraction as measured by echocardiography will be measured prior to discharge or up to 180 days post hospital discharge.
Time Frame
30 days and 180 days
Title
Cognitive functional status
Description
As measured by Modified Rankin Score (mRS) and Cerebral Performance Category (CPC) at multiple points up to 180 days post hospital discharge
Time Frame
180 days
Title
Neurocognitive Testing
Description
Neurocognitive function will be assessed at various time points utilizing a variety of tests from ICU discharge to 180 days post hospital discharge such as MMSE, MOCA, HADS, and IQCODE
Time Frame
180 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All successfully resuscitated out-of-hospital cardiac arrest patients with a suspected cardiac etiology for their non-traumatic arrest
Age greater than 18 years
The post resuscitation ECG shows no evidence of ST segment elevation
Exclusion Criteria:
Non-resuscitated (no sustained pulse and BP)
Presence ST segment elevation or new left bundle branch block present on the post-resuscitation ECG
Suspected non-cardiac etiology for their arrest such as respiratory failure, asphyxia, pulmonary embolus, shock, trauma, drug overdose, or CNS bleed as likely cause of the cardiac arrest
Known "Do Not Resuscitate" status
Minors (<18 years old)
Prisoners
Significant bleeding or blunt trauma
Known or confirmed pregnancy test by urinalysis
Patients who are known to have received any other investigational therapies within the 30 days prior to enrollment or during study duration will be excluded unless these studies have been reviewed and approved by the Study Steering Committee.
Known "opt out" choice; wearing Opt-out band for any EFIC approved study or on an "Opt-out" list
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karl B Kern, MD
Organizational Affiliation
University of Arizona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Banner University Medical Center-South Campus
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States
Facility Name
Banner University Medical Center-Tucson Campus
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States
Facility Name
Tufts University School of Medicine, Maine Medical Center
City
Portland
State/Province
Maine
ZIP/Postal Code
04103
Country
United States
Facility Name
Mayo Clinic Cardiovascular Research Unit
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Facility Name
Alfred Hospital
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3004
Country
Australia
Facility Name
University Medical Center Ljubljana
City
Ljubljana
Country
Slovenia
12. IPD Sharing Statement
Plan to Share IPD
Yes
Citations:
PubMed Identifier
32985249
Citation
Kern KB, Radsel P, Jentzer JC, Seder DB, Lee KS, Lotun K, Janardhanan R, Stub D, Hsu CH, Noc M. Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: The PEARL Study. Circulation. 2020 Nov 24;142(21):2002-2012. doi: 10.1161/CIRCULATIONAHA.120.049569. Epub 2020 Sep 28. Erratum In: Circulation. 2020 Nov 24;142(21):e374.
Results Reference
derived
Learn more about this trial
Early Coronary Angiography Versus Delayed Coronary Angiography
We'll reach out to this number within 24 hrs